Evidence map›Paper›PMID 27469353›Full record

ArticleInternational journal of public health2016

Investigating mortality heterogeneity among neighbourhoods of a highly industrialised Italian city: a meta-regression approach.

Emilio Antonio Luca Gianicolo, Cristina Mangia, Marco Cervino

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emilio Antonio Luca GianicoloInstitute of Clinical Physiology, National Research Council, Lecce, Italy. gianicolo@uni-mainz.de.
Cristina MangiaInstitute of Atmospheric Sciences and Climate, National Research Council, s.p. Lecce-Monteroni km 1.2, 73100, Lecce, Italy.
Marco CervinoInstitute of Atmospheric Sciences and Climate, National Research Council, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe purpose of this study was to investigate the role of various predictors to explain spatial mortality heterogeneity in Taranto.

methodsDirect age-adjusted death rates (ADR) at a neighbourhood level for the period 1998-2010 were examined. SO2, PM10, distance from pollution sources, and socioeconomic status (SES) were tested as predictors within a meta-regression framework. We used τ (2) to quantify heterogeneity in ADR and I (2) statistic with 95 % confidence intervals to estimate the proportion of total variation across neighbourhoods attributable to the between-neighbourhood heterogeneity.

resultsHigh heterogeneity resulted for all and natural causes of death for both genders. One neighbourhood (Paolo VI) was detected as an outlier for all predictors except SO2, among males. After accounting for SES, moderate heterogeneity among residuals was observed for all-causes of death and was correlated with SO2. Higher concentrations of PM10 were observed in neighbourhoods close to the industrial site and higher concentrations of SO2 in neighbourhoods more distant from the industrial site.

conclusionsSES and air pollutants were predictors of spatial heterogeneity in ADR. Different distributions of SO2 and PM10 in the city suggested two exposure patterns.

Indexed as

MortalityAir PollutantsAir PollutionCardiovascular DiseasesCause of DeathCitiesEnvironmental ExposureFemaleHumansIndustryItalyMaleNeoplasmsParticulate MatterRespiratory Tract DiseasesSex DistributionAir PollutantsParticulate MatterSulfur DioxideAir pollutionMeta-analysisMortality differencesSocioeconomic statusTaranto

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.